RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $68,000 | -1.4% | 24,196 | +0.4% | 0.00% | – |
| Q4 2020 | $69,000 | +43.8% | 24,096 | +6.3% | 0.00% | – |
| Q3 2020 | $48,000 | -60.0% | 22,676 | -14.3% | 0.00% | – |
| Q2 2020 | $120,000 | -42.3% | 26,451 | +3.8% | 0.00% | – |
| Q1 2020 | $208,000 | -55.1% | 25,479 | +1.0% | 0.00% | -100.0% |
| Q4 2019 | $463,000 | +67.8% | 25,235 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $276,000 | +8.2% | 24,910 | -0.5% | 0.00% | – |
| Q2 2019 | $255,000 | +86.1% | 25,025 | +7.0% | 0.00% | – |
| Q1 2019 | $137,000 | -18.9% | 23,396 | -1.5% | 0.00% | – |
| Q4 2018 | $169,000 | +48.2% | 23,753 | +47.8% | 0.00% | – |
| Q3 2018 | $114,000 | +35.7% | 16,074 | -4.3% | 0.00% | – |
| Q2 2018 | $84,000 | -39.6% | 16,804 | +33.4% | 0.00% | – |
| Q1 2018 | $139,000 | +20.9% | 12,595 | +1.1% | 0.00% | – |
| Q4 2017 | $115,000 | -16.7% | 12,455 | -19.2% | 0.00% | – |
| Q3 2017 | $138,000 | +60.5% | 15,411 | +26.5% | 0.00% | – |
| Q2 2017 | $86,000 | – | 12,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |